Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susanne Poley"'
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58:1247-1253
In order to address the European Directive 2004/23 on human tissues and cells, the authorization obligation for tissue and blood stem cell preparations was introduced (§ 21a AMG) in the year 2007 in the German medicinal products act. Stem cell trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fd89316f7e46d4d14b74f6421598780
https://doi.org/10.1007/s00103-015-2241-3
https://doi.org/10.1007/s00103-015-2241-3
Autor:
Ute, Vahlensieck, Susanne, Poley-Ochmann, Anneliese, Hilger, Margarete, Heiden, Rainer, Seitz
Publikováno v:
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 58(11-12)
In order to address the European Directive 2004/23 on human tissues and cells, the authorization obligation for tissue and blood stem cell preparations was introduced (§ 21a AMG) in the year 2007 in the German medicinal products act. Stem cell trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14dd40878e4b0b9f7b4fb360125f081a
https://pubmed.ncbi.nlm.nih.gov/26459568
https://pubmed.ncbi.nlm.nih.gov/26459568
Publikováno v:
Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz. 48:408-414
Clinical trials play a central role in clinical development for achieving marketing authorization for a drug. Carefully planned and carried out clinical trials allow for valid conclusions on the efficacy and/or safety of a drug. In order to do so, va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::409cccbcba6d75b0a702fcb74a9832d9
https://doi.org/10.1007/s00103-005-1014-9
https://doi.org/10.1007/s00103-005-1014-9
Autor:
Wolfgang Mempel, Susanne Poley
Publikováno v:
European Journal of Haematology. 66:253-262
Nearly one third of patients with heparin-induced thrombo- cytopenia (HIT) will progress to overt thrombosis. Owing to the severity of HIT, a reliable prompt diagnosis is mandatory. In this study 248 consecutive samples from patients referred to our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71e2a5131061988e114db2e2f3c825bd
https://doi.org/10.1034/j.1600-0609.2001.066004253.x
https://doi.org/10.1034/j.1600-0609.2001.066004253.x
Autor:
Susanne Poley, Christian L. Müller, Karin Hofmann, H. Dienemann, A. Fateh-Moghadam, U Hasholzner, Petra Stieber
Publikováno v:
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies. 31(10)
Recently CYFRA 21-1, a new tumour marker measuring a fragment of cytokeratin 19, was introduced and proved to be suitable for the follow-up care and monitoring of the therapy of non-small cell lung carcinomas, especially squamous cell carcinomas of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb94aaa0d27223685e4e537991b040a
https://pubmed.ncbi.nlm.nih.gov/7507359
https://pubmed.ncbi.nlm.nih.gov/7507359